Navigation Links
New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
Date:11/2/2007

CHAPEL HILL, N.C., Nov. 2 /PRNewswire/ -- Just how much of the time that sales people should be spending with the customer is lost due to administrative tasks and internal communication?

Pharmaceutical sales directors agree the answer is 'too much time' - in fact, 32% of the time used for internal communication - or 6 weeks per rep per year - is unnecessary and causes millions in lost sales every year, according to a recent research study by Best Practices, LLC. But yet, understanding and implementing the key tactics that make a more productive sales force remains a daily challenge.

The report, "Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication," (free report excerpt at: http://www3.best-in-class.com/rr873.htm) highlights specific practices and performance metrics you can implement today to see immediate results in sales team efficiency and bottom-line revenues.

Findings were collected from surveys and interviews with sales leaders and field sales staff at leading companies, including: Pfizer, Sanofi-Aventis, Purdue Pharma, Janssen, Merck, Eli Lilly, Johnson & Johnson, Ortho-McNeil, Genentech and Allergan.

This report is packed with sales communication metrics and productivity practices. Some of them include:

- Poorly prioritized or redundant communication between pharma sales reps

and their managers causes an estimated $309,000 in annual lost sales

per sales rep.

- Pharma sales reps spend an average of 13.7 hours a week managing

internal communication. Most of this time is spent managing email,

checking voicemail and talking on a cell phone. Of this time, 4.4 hours

(or 32%) are perceived to be unnecessary.

- District managers estimated that they spent 36.5 hours per week

managing internal communication. That's an amazing 1,825 hours per year

per manager.

- Savvy district managers forward emails with a tag in the subject line

that indicates whether the information is "need-to-know" or "nice-to-

know."

- Improve access to online information that can be downloaded and doesn't

need to be delivered through voicemail, email or paper

Download additional sample findings and metrics from the complimentary report excerpt at: http://www3.best-in-class.com/rr873.htm

To drill down on the insights presented in this report more deeply contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com.

If you have questions about this report or would like to speak to us about how our research can benefit your Sales Force Operations or other initiatives in your company, please contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. South Africa Wins landmark case against pharmaceutical giants
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Setting up a new pharmaceutical industry in India
5. Medicis Pharmaceutical company enters pediatric market
6. Supply of Radiopharmaceuticals Hampered by Attacks
7. Pharmaceutical companies are targeting patients
8. FDA approves Watson Pharmaceuticals Oxytrol patch
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... The 89th Academy ... winner of the 2016 National Education Policy Center Bunkum Award. We invite you to ... 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), for ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, which is ... in Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) ... website, weekly e-newsletter and quarterly publication, will be conducting interviews with patients and ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Los Angeles-based ... episodes of WE TV’s “Mama June: From Not to Hot,” which will begin airing ... “Mama” June Shannon, known to millions from the 2012 reality television series, “Here Comes ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... on “Doping in Sport: How the Culture Might Change,” in conjunction ... The symposium will be held at Pepperdine University in Malibu, California. , Sir ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market Pty ... have joined forces, resulting in the founding of Pharma To Market ... Pharma To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... of the Singapore based entity. Joelle brings ...
(Date:2/24/2017)... Feb 24, 2017 Medivir AB ... for a new Board of Directors that will be ... Nomination Committee comprises representatives of the company,s three largest ... 2016 who have accepted a seat on the Nomination ... of the 2016-2017 Nomination Committee was as follows:  ...
(Date:2/23/2017)... Research and Markets has announced the addition ... - 2016" report to their offering. ... The latest research Autism Spectrum Disorder ... and benchmarks in the global Autism Spectrum Disorder market. The ... are the key drugs marketed for Autism Spectrum Disorder and their ...
Breaking Medicine Technology: